title: The measurement of arterial smooth muscle cell mitogens in the blood of oral contraceptive users.
abstract: We have previously shown that serum from young women receiving the same combined mestranol-norethindrone containing oral contraceptive (OC) preparation accelerated the proliferation of arterial smooth muscle cells (SMC) in tissue culture, and this in vitro effect was not a direct action of either of its estrogenic or progestogenic constituents. To identify the substance(s) which might contribute to this potentially atherogenic action, blood was obtained from 20 OC users and control women for the measurement of growth hormone, insulin, somatomedins (insulin-like growth factor IGF-I and IGF-II), and the platelet alpha-granule constituents platelet-derived growth factor (PDGF), beta-thromboglobulin, and platelet factor 4 (PF4). No difference was demonstrable between OC users and controls in the levels of any of these growth-promoting hormones, nor in plasma concentrations of any of the platelet alpha-granule proteins. These studies indicate that the enhanced mitogenicity found in OC sera is probably not attributable directly to these hormones or PDGF, and may instead result from an in vivo OC-induced alteration in other as yet unidentified mediators of cellular growth.
authors.forename: J D
authors.initials: JD
authors.lastname: Bagdade
authors.forename: P V
authors.initials: PV
authors.lastname: Subbaiah
authors.forename: R L
authors.initials: RL
authors.lastname: Hintz
authors.forename: D M
authors.initials: DM
authors.lastname: Wilson
mesh_terms: D000293:Adolescent; D000328:Adult; D001158:Arteries / Q000187:drug effects; D003277:Contraceptives, Oral, Combined / Q000494:pharmacology; D003278:Contraceptives, Oral, Hormonal / Q000494:pharmacology*; D004338:Drug Combinations; D005260:Female; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007328:Insulin / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000097:blood; D007335:Insulin-Like Growth Factor II / Q000097:blood; D008656:Mestranol / Q000494:pharmacology; D008934:Mitogens / Q000097:blood*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D009640:Norethindrone / Q000494:pharmacology; D010976:Platelet Count; D010978:Platelet Factor 4 / Q000032:analysis; D001620:beta-Thromboglobulin / Q000032:analysis
chemical_list: D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D004338:Drug Combinations; D007328:Insulin; D008934:Mitogens; D001620:beta-Thromboglobulin; D010978:Platelet Factor 4; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II; C014715:Norinyl; D013006:Growth Hormone; D008656:Mestranol; D009640:Norethindrone